4
Changes in Ownership
TransMedics Group, Inc. Filed Acc 0000950170-24-040393
Chief Financial Officer sold 15,000 shares at $74.01 ($1,110,150)
- Chief Financial Officer acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gordon Stephen · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $38.46 | $576,900 | 38,299 | D |
| 2024-04-01 | Sale : show line 2 in the form 10b5-1 | −15,000 | $74.01 | $1,110,150 | 23,299 | D |
| Open-market sales · 15,000 sh · avg $74.01 · $1,110,150 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −15,000 | 37,477 | D |
Loading xslF345X05/ownership.xml…